Adhering to best practice guidelines in outcomes measurement

被引:0
作者
Morley, David [1 ]
Jenkinson, Crispin [1 ]
机构
[1] Univ Oxford, Nuffield Dept Populat Hlth, Old Rd Campus, Oxford OX3 7LF, England
关键词
FDA guidelines; Outcomes measurement; Patient reported outcome measure; PDQ-39; PROM; ACTIVITIES QUESTIONNAIRE; OXFORD PARTICIPATION; PARKINSONS-DISEASE; VALIDATION;
D O I
10.1016/j.neubiorev.2018.07.021
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Parkinson's disease (PD) is traditionally classified as a movement disorder because patients mainly complain about motor symptoms. Recently, non-motor symptoms of PD have been recognized by clinicians and scientists as early signs of PD, and they are detrimental factors in the quality of life in advanced PD patients. It is crucial to comprehensively understand the essence of behavioral assessments, from the simplest measurement of certain symptoms to complex neuropsychological tasks. We have recently reviewed behavioral assessments in PD research with animal models (Asakawa et al., 2016). As a companion volume, this article will systematically review the behavioral assessments of motor and non-motor PD symptoms of human patients in current research. The major aims of this article are: (1) promoting a comparative understanding of various behavioral assessments in terms of the principle and measuring indexes; (2) addressing the major strengths and weaknesses of these behavioral assessments for a better selection of tasks/tests in order to avoid biased conclusions due to inappropriate assessments; and (3) presenting new concepts regarding the development of wearable devices and mobile intemet in future assessments. In conclusion we emphasize the importance of improving the assessments for non-motor symptoms because of their complex and unique mechanisms in human PD brains.
引用
收藏
页码:196 / 197
页数:2
相关论文
共 12 条
  • [1] [Anonymous], 2004, EMEACHMPEWP139391200
  • [2] Human behavioral assessments in current research of Parkinson's disease
    Asakawa, Tetsuya
    Fang, Huan
    Sugiyama, Kenji
    Nozaki, Takao
    Kobayashi, Susumu
    Hong, Zhen
    Suzuki, Katsuaki
    Mori, Norio
    Yang, Yilin
    Hua, Fei
    Ding, Guanghong
    Wen, Guoqiang
    Namba, Hiroki
    Xia, Ying
    [J]. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2016, 68 : 741 - 772
  • [3] COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) website, 2018, CONSENSUS BAS STAND
  • [4] Food and Drug Administration Department of Health and Human Sciences. Guidance to Industry, 2009, US MED PROD DEV SUPP
  • [5] Jenkinson C, 2012, The Parkinson's Disease Questionnaires: User Manual (PDQ-39, PDQ-8, PDQ Summary Index & PDQ-carer)
  • [6] Development of the Oxford Participation and Activities Questionnaire: constructing an item pool
    Kelly, Laura
    Jenkinson, Crispin
    Dummett, Sarah
    Dawson, Jill
    Fitzpatrick, Ray
    Morley, David
    [J]. PATIENT-RELATED OUTCOME MEASURES, 2015, 6 : 145 - 155
  • [7] Validation of the Oxford Participation and Activities Questionnaire
    Morley, David
    Dummett, Sarah
    Kelly, Laura
    Dawson, Jill
    Fitzpatrick, Ray
    Jenkinson, Crispin
    [J]. PATIENT-RELATED OUTCOME MEASURES, 2016, 7 : 73 - 80
  • [8] The Oxford Participation and Activities Questionnaire: study protocol
    Morley, David
    Dummett, Sarah
    Kelly, Laura
    Dawson, Jill
    Fitzpatrick, Ray
    Jenkinson, Crispin
    [J]. PATIENT-RELATED OUTCOME MEASURES, 2014, 5 : 1 - 6
  • [9] Evaluating the psychometric properties of an e-based version of the 39-item Parkinson's Disease Questionnaire
    Morley, David
    Dummett, Sarah
    Kelly, Laura
    Dawson, Jill
    Jenkinson, Crispin
    [J]. HEALTH AND QUALITY OF LIFE OUTCOMES, 2015, 13
  • [10] An Electronic Version of the PDQ-39: Acceptability to Respondents and Assessment of Alternative Response Formats
    Morley, David
    Dummett, Sarah
    Kelly, Laura
    Dawson, Jill
    Jenkinson, Crispin
    [J]. JOURNAL OF PARKINSONS DISEASE, 2014, 4 (03) : 467 - 472